111 Group

Guangzhou, China Founded: 2010 • Age: 16 yrs Listed
Online pharmacy for selling pharmaceuticals and health products

About 111 Group

111 Group is a publicly listed company based in Guangzhou (China) founded in 2010 by Gang Yu. 111 Group has raised $122 million across 4 funding rounds from investors including Zhangjiang Torch Venture Capital, GeniLink Capital and Shanghai STVC Group. The company has 1,240 employees. Its chief executive, as recorded, is Junling Liu. Its website 111.com.cn draws about 228 thousand monthly visits. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include AliHealth, IvyBaby and Alibaba Health; 1 of its 3 listed competitors has raised funding.

Company details

Online pharmacy for selling pharmaceuticals and health products. It is an online drugstore that sells over-the-counter medications, traditional Chinese remedies, and a variety of other health products such as dental products, contact lenses, baby and mother care products, etc.

  • Headquarters Guangzhou, China
  • Employees 1,240
  • Founders Gang Yu
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Website 111.com.cn
  • Legal Name 111, Inc. Sponsored Adr
Key Metrics
  • Annual Revenue
    $1.75 B (USD)
    -12.71
    as on Dec 31, 2025
  • Net Profit
    -$9.24 M (USD)
    -2.67
    as on Dec 31, 2025
  • EBITDA
    $212.98 K (USD)
    -85.7
    as on Dec 31, 2025
  • Total Equity Funding
    $122M (USD)

    in 4 rounds

  • Latest Funding Round
    $78.75M (USD), Post-IPO

    Dec 2020

  • Investors
  • Employee Count
    1,240

Funding Insights of 111 Group

111 Group has successfully raised a total of $122M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $78.75 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $122M
  • Total Rounds 4
  • Last Round Post-IPO β€” $78.75M
  • Investors Count 7

All 4 funding rounds of 111 Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2020$78.75MPost-IPO––
Apr 2018$50MSeries C–6 Dimensions Capital
–
Jan 2015$72MSeries C––
–
Jun 2014Series C–Verlinvest
–
Valuation history

7 investors in total: 7 institutional.

Investors in 111 Group

111 Group has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Zhangjiang Torch Venture Capital, GeniLink Capital and Shanghai STVC Group.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
zjhjf.com
Venture capital firm focused on tech sectors
genilinkcap.comShanghai, China
Venture capital firm investing in medical tech startups
shstvc.com.cnShanghai, China
Venture capital firm focused on technology, health, and industry upgrade products
ideateventures.comShanghai, China
A leading private equity firm supporting high-growth enterprises in Asia.
saifpartners.com.cnChaoyang, China
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
6dimensionscapital.comPudong, China
Single family office of a Belgian family focused on multiple industries
verlinvest.comBrussels, Belgium
Premium access

Investor details for 111 Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of 111 Group

5 people are tracked at 111 Group (4 in leadership, 1 in team); the tracked headcount is 1,240.

NameRoleGroup
Gang Yu
Co-FounderLeadership
Junling Liu
Chairman & CEOLeadership
Luke Chen
Chief Financial Officer and DirectorLeadership
Carter Huang
Senior Finance DirectorLeadership
Lion Qian
药店赋能事业部负责人Team
Premium access

Complete people profiles for 111 Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of 111 Group

111 Group is a publicly listed company on the NASDAQ with ticker symbol YI in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Sep 2018
  • Listed onFRA: 811A
  • Listed entity111, Inc. Sponsored ADR
  • Exchange sectorDistribution services
  • ISINUS68247Q2012
  • Share price$3.10 (-0.32% on the day) · 2026-10-13
  • Market capitalisation$27.2M
  • EPS (diluted, trailing year)$-1.73
  • Volume (last session)33,800

Financials of 111 Group

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$1.75B-$9.2M$212,980
2024$2.00B-$9.0M$1.5M
2023$2.11B-$55.4M-$46.1M
2022$2.01B-$61.9M-$48.1M
2021$1.93B-$103.9M-$95.7M
Premium access

Detailed financial statements for 111 Group

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of 111 Group

4 dated milestones of 111 Group across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded 111 Group is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $78.8M.

Competitors of 111 Group

111 Group has 3 listed competitors in our database, 1 of them funded. They include AliHealth, IvyBaby and Alibaba Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
alijk.com2004China
Healthtech services like telemedicine and O2O drug delivery are offered.
ivybaby.me2014Beijing, China$1.5M
Baby health monitoring and management tools are offered to parents.
alihealth.cn1998Beijing, China2
Online platform for pharmacy, consultations, and appointments is operated.
Premium access

Detailed competitors of 111 Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of 111 Group

The website of 111 Group (111.com.cn) receives about 228.1K visits a month and ranks #117,901 among all websites worldwide, #3,512 in Health.

  • Monthly visits
    228.1K

    ▲ 5.6% vs previous month

  • Unique visitors
    44.9K

    per month

  • Global rank
    #117,901

    among all websites

  • Category rank
    #3,512

    Health · Health

Similar websites

Websites whose visitors overlap most with 111 Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jxdyf.com
100%
View details
j1.com
98%
View details
818.com
818.com
96%
–
360kad.com
91%
View details
360kxr.com
360kxr.com
86%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for 111 Group

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about 111 Group

Premium access

Complete news archive for 111 Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about 111 Group

111 Group was founded in 2010 and raised its 1st funding round 4 years after it was founded.

111 Group is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.

Junling Liu is the CEO of 111 Group, as recorded in our data.

111 Group is a funded company, having raised a total of $122M across 4 funding rounds to date.

111 Group has 1,240 employees.

Annual revenue of 111 Group is $1.75B as on Dec 31, 2025.

Online pharmacy for selling pharmaceuticals and health products. It is an online drugstore that sells over-the-counter medications, traditional Chinese remedies, and a variety of other health products such as dental products, contact lenses, baby and mother care products, etc.

111 Group's top competitors include Alibaba Health, IvyBaby and AliHealth.

Yes, 111 Group is publicly traded on NASDAQ under the ticker symbol YI.

111 Group has 7 investors. Key investors include Zhangjiang Torch Venture Capital, GeniLink Capital, Shanghai STVC Group, Ideate Investments, and SAIF Partners China.

The website of 111 Group receives about 228 thousand visits a month and ranks #117,901 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available